Market Cap (In KRW)
139.09 Billion
Revenue (In KRW)
87.36 Billion
Net Income (In KRW)
-118.26 Billion
Avg. Volume
4.45 Million
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 611.0-3080.0
- PE
- -
- EPS
- -
- Beta Value
- -0.009
- ISIN
- KR7003060001
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jeong-Chool Kim
- Employee Count
- -
- Website
- https://en.aprogen-pharm.com/index.do
- Ipo Date
- 2000-01-04
- Details
- Aprogen pharmaceuticals,Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics. The company was formerly known as Schnell Biopharmaceuticals, Inc. and changed its name to Aprogen pharmaceuticals,Inc. in April 2017. Aprogen pharmaceuticals,Inc. was founded in 1960 and is headquartered in Seongnam, South Korea.
More Stocks
-
HEXABSHexagon AB
HEXABS
-
7751Canon Inc.
7751
-
3306JNBY Design Limited
3306
-
SNGS
-
INDIANHUMEThe Indian Hume Pipe Company Limited
INDIANHUME
-
1701
-
PIAPiaggio & C. SpA
PIA
-
GNA